Hawaii HB553 mandates coverage for biomarker testing in health insurance policies and contracts starting January 1, 2026.
Hawaii HB553 amends state statutes to require coverage for biomarker testing in health insurance policies and contracts issued or renewed after January 1, 2026. Biomarker testing includes analysis of tissue, blood, or other biospecimens to detect indicators of biological processes, disease, or responses to therapeutic interventions. Insurers and health maintenance organizations must provide written notice to policyholders and subscribers about this coverage by December 31, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.